Inspire Medical Systems, Inc. Selling and Marketing Expense
Inspire Medical Systems, Inc. (INSP) reported Selling and Marketing Expense of $11.31 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2018-11-06
- Inspire Medical Systems, Inc. selling and marketing expense for the quarter ending 2018-09-30 was $11.31M, a 54.64% increase year-over-year.
- Inspire Medical Systems, Inc. selling and marketing expense for the quarter ending 2018-06-30 was $10.73M, a 64.97% increase year-over-year.
- Inspire Medical Systems, Inc. selling and marketing expense for the quarter ending 2018-03-31 was $9.87M, a 71.77% increase year-over-year.
- Inspire Medical Systems, Inc. selling and marketing expense for the quarter ending 2017-09-30 was $7.32M.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month |
|---|---|---|---|
| 2018-09-30 | $11.31M 10-Q · filed 2018-11-06 | $22.05M derived: sum of 2 quarters · filed 2018-11-06 | $31.91M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $10.73M 10-Q · filed 2018-08-07 | $20.60M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $9.87M 10-Q · filed 2018-06-07 | ||
| 2017-09-30 | $7.32M 10-Q · filed 2018-11-06 | $13.82M derived: sum of 2 quarters · filed 2018-11-06 | $19.57M 10-Q · filed 2018-11-06 |
| 2017-06-30 | $6.51M 10-Q · filed 2018-08-07 | $12.25M 10-Q · filed 2018-08-07 | |
| 2017-03-31 | $5.75M 10-Q · filed 2018-06-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |